Search research articles
Contact Us
Filters
Showing results (191-200 of 219) with videos related to
Page
of 22
Sort By:
Chinese Medical Journal
|
April 27, 2011
A prospective multicenter parallel-controlled trial of TIVOLI biodegradable-polymer-based sirolimus-eluting stent compared to ENDEAVOR zotarolimus-eluting stent for the treatment of coronary artery disease: 8-month angiographic and 2-year clinical follow-up results
Bo Xu, Ke-fei Dou, Ya-ling Han, et al.
Chinese Medical Journal
|
September 8, 2010
Thorombolytic therapy with rescue percutaneous coronary intervention versus primary percutaneous coronary intervention in patients with acute myocardial infarction: a multicenter randomized clinical trial
Run-lin Gao, Ya-ling Han, Xin-chun Yang, et al.
Journal of Cardiology
|
March 15, 2016
Five-year outcomes of ST-elevation myocardial infarction versus non-ST-elevation acute coronary syndrome treated with biodegradable polymer-coated sirolimus-eluting stents: Insights from the CREATE trial
Hui-Liang Liu, Zhi-Geng Jin, Sheng-Li Yang, et al.
Journal of Thrombosis and Thrombolysis
|
November 19, 2011
Pharmacoinvasive therapy for ST elevation myocardial infarction in China: a pilot study
Ling-hong Shen, Fang Wan, Long Shen, et al.
Heliyon
|
November 25, 2024
Implications of baseline glycemic control by plasma glycated hemoglobin A1c on adverse outcomes in patients with coronary heart disease and type 2 diabetes mellitus: Results from the PROMISE study
Xiao-Fang Tang, Qin-Xue Li, Ya-Ling Han, et al.
European Heart Journal. Cardiovascular Pharmacotherapy
|
January 17, 2023
Ticagrelor with or without aspirin in high-risk patients with anaemia undergoing percutaneous coronary intervention: a subgroup analysis of the TWILIGHT trial
Alessandro Spirito, Adnan Kastrati, Davide Cao, et al.
Journal of the American College of Cardiology
|
March 16, 2013
Comparison of double kissing crush versus Culotte stenting for unprotected distal left main bifurcation lesions: results from a multicenter, randomized, prospective DKCRUSH-III study
Shao-Liang Chen, Bo Xu, Ya-Ling Han, et al.
JACC. Cardiovascular Interventions
|
October 20, 2014
Impact of the complexity of bifurcation lesions treated with drug-eluting stents: the DEFINITION study (Definitions and impact of complEx biFurcation lesIons on clinical outcomes after percutaNeous coronary IntervenTIOn using drug-eluting steNts)
Shao-Liang Chen, Imad Sheiban, Bo Xu, et al.
American Heart Journal
|
March 8, 2024
Ticagrelor with or without aspirin following percutaneous coronary intervention in high-risk patients with concomitant peripheral artery disease: A subgroup analysis of the TWILIGHT randomized clinical trial
Mitchell Krucoff, Alessandro Spirito, Usman Baber, et al.
The American Journal of Cardiology
|
October 8, 2023
Clinically Driven Revascularization in High-Risk Patients Treated With Ticagrelor Monotherapy After PCI: Insights from the Randomized TWILIGHT Trial
Usman Baber, Alessandro Spirito, Samantha Sartori, et al.
Page
of 22
Search research articles
Search
Showing results (191-200 of 219) with videos related to
Sort By:
Page
of 22
Chinese Medical Journal
|
April 27, 2011
A prospective multicenter parallel-controlled trial of TIVOLI biodegradable-polymer-based sirolimus-eluting stent compared to ENDEAVOR zotarolimus-eluting stent for the treatment of coronary artery disease: 8-month angiographic and 2-year clinical follow-up results
Bo Xu, Ke-fei Dou, Ya-ling Han, et al.
Chinese Medical Journal
|
September 8, 2010
Thorombolytic therapy with rescue percutaneous coronary intervention versus primary percutaneous coronary intervention in patients with acute myocardial infarction: a multicenter randomized clinical trial
Run-lin Gao, Ya-ling Han, Xin-chun Yang, et al.
Journal of Cardiology
|
March 15, 2016
Five-year outcomes of ST-elevation myocardial infarction versus non-ST-elevation acute coronary syndrome treated with biodegradable polymer-coated sirolimus-eluting stents: Insights from the CREATE trial
Hui-Liang Liu, Zhi-Geng Jin, Sheng-Li Yang, et al.
Journal of Thrombosis and Thrombolysis
|
November 19, 2011
Pharmacoinvasive therapy for ST elevation myocardial infarction in China: a pilot study
Ling-hong Shen, Fang Wan, Long Shen, et al.
Heliyon
|
November 25, 2024
Implications of baseline glycemic control by plasma glycated hemoglobin A1c on adverse outcomes in patients with coronary heart disease and type 2 diabetes mellitus: Results from the PROMISE study
Xiao-Fang Tang, Qin-Xue Li, Ya-Ling Han, et al.
European Heart Journal. Cardiovascular Pharmacotherapy
|
January 17, 2023
Ticagrelor with or without aspirin in high-risk patients with anaemia undergoing percutaneous coronary intervention: a subgroup analysis of the TWILIGHT trial
Alessandro Spirito, Adnan Kastrati, Davide Cao, et al.
Journal of the American College of Cardiology
|
March 16, 2013
Comparison of double kissing crush versus Culotte stenting for unprotected distal left main bifurcation lesions: results from a multicenter, randomized, prospective DKCRUSH-III study
Shao-Liang Chen, Bo Xu, Ya-Ling Han, et al.
JACC. Cardiovascular Interventions
|
October 20, 2014
Impact of the complexity of bifurcation lesions treated with drug-eluting stents: the DEFINITION study (Definitions and impact of complEx biFurcation lesIons on clinical outcomes after percutaNeous coronary IntervenTIOn using drug-eluting steNts)
Shao-Liang Chen, Imad Sheiban, Bo Xu, et al.
American Heart Journal
|
March 8, 2024
Ticagrelor with or without aspirin following percutaneous coronary intervention in high-risk patients with concomitant peripheral artery disease: A subgroup analysis of the TWILIGHT randomized clinical trial
Mitchell Krucoff, Alessandro Spirito, Usman Baber, et al.
The American Journal of Cardiology
|
October 8, 2023
Clinically Driven Revascularization in High-Risk Patients Treated With Ticagrelor Monotherapy After PCI: Insights from the Randomized TWILIGHT Trial
Usman Baber, Alessandro Spirito, Samantha Sartori, et al.
Page
of 22